BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2692417)

  • 1. Renal function as affected by inhibitors of kininase II and of neutral endopeptidase 24.11 in rats with and without desoxycorticosterone pretreatment.
    Nakagawa M; Nasjletti A
    Adv Exp Med Biol; 1989; 247B():495-9. PubMed ID: 2692417
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of a kinin antagonist on renal function in rats.
    Nakagawa M; Stewart JM; Vavrek RJ; Nasjletti A
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F643-8. PubMed ID: 1690517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enkephalinase inhibition increases plasma atrial natriuretic peptide levels, glomerular filtration rate, and urinary sodium excretion in rats with reduced renal mass.
    Lafferty HM; Gunning M; Silva P; Zimmerman MB; Brenner BM; Anderson S
    Circ Res; 1989 Sep; 65(3):640-6. PubMed ID: 2548762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo.
    Ura N; Carretero OA; Erdös EG
    Kidney Int; 1987 Oct; 32(4):507-13. PubMed ID: 2828746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NaCl modulates captopril effects on glomerular prostaglandin synthesis and glomerular filtration.
    Rathaus M; Podjarny E; Pomeranz A; Bernheim J
    Am J Physiol; 1990 Feb; 258(2 Pt 2):F382-7. PubMed ID: 2106794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I; Gonzalez W; el Amrani AI; Fournié-Zaluski MC; Philippe M; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK 506-induced nephrotoxicity in rats.
    Kumano K; Wang G; Endo T; Kuwao S
    Transplant Proc; 1991 Feb; 23(1 Pt 1):512-5. PubMed ID: 1703696
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats.
    Ying L; Flamant M; Vandermeersch S; Boffa JJ; Chatziantoniou C; Dussaule JC; Chansel D
    Hypertension; 2003 Nov; 42(5):937-44. PubMed ID: 14569001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
    Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
    J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feedback regulation of glomerular filtration rate.
    Wright FS; Briggs JP
    Am J Physiol; 1977 Jul; 233(1):F1-7. PubMed ID: 327832
    [No Abstract]   [Full Text] [Related]  

  • 11. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.
    Seymour AA; Asaad MM; Abboa-Offei BE; Smith PL; Rogers WL; Dorso CR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):708-13. PubMed ID: 8632340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
    Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
    J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension following adrenal enucleation and its absence during desoxycorticosterone treatment in Long-Evans rats.
    Hall CE; Ayachi S; Hall O
    Endocrinology; 1973 Apr; 92(4):1175-81. PubMed ID: 4686314
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin converting enzyme inhibition and autoregulation of glomerular filtration.
    Plante GE; Chainey A; Sirois P; Devissaguet M
    J Hypertens Suppl; 1988 Dec; 6(3):S69-73. PubMed ID: 3066878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal interstitial pressure in mineralocorticoid escape.
    Burnett JC; Haas JA; Larson MS
    Am J Physiol; 1985 Sep; 249(3 Pt 2):F396-9. PubMed ID: 4037091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct renal action of captopril (SQ 14225): dissociation of natriuretic and vascular actions in isolated perfused rat kidney.
    Ogihara T; Yasui T; Nakane H; Nakane Y; Satura T
    Am J Cardiol; 1982 Apr; 49(6):1511-2. PubMed ID: 7041588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of DOCA-salt on angiotensin dependency and surgical reversal of hypertension in two-kidney, one clip renal hypertensive rats.
    Takata Y; Doyle AE
    J Hypertens; 1983 Jun; 1(1):57-63. PubMed ID: 6397514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
    Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
    Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidase inhibitors reverse steroid-induced suppression of neutrophil adhesion in rat tracheal blood vessels.
    Katayama M; Nadel JA; Piedimonte G; McDonald DM
    Am J Physiol; 1993 Mar; 264(3 Pt 1):L316-22. PubMed ID: 8460720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
    Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
    Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.